Kacy Wiggum
About Kacy Wiggum
Kacy Wiggum is the Senior Corporate Counsel for US Market Access, Pricing, and Value Demonstration at Bristol Myers Squibb, with extensive experience in regulatory law and a background in communications.
Title
Kacy Wiggum is the Senior Corporate Counsel for US Market Access, Pricing and Value Demonstration, Regulatory Law at Bristol Myers Squibb.
Company
Kacy Wiggum currently works at Bristol Myers Squibb, a major pharmaceutical company known for its innovative therapies and commitment to improving patient outcomes.
Previous Positions
Before becoming the Senior Corporate Counsel at Bristol Myers Squibb, Kacy Wiggum served in several significant roles. They were the Senior Counsel US Market Access/Value, Access & Payment at Bristol Myers Squibb from 2022 to 2024. Prior to that, they were the Director at Bausch Health Companies Inc. for 3 years, from 2019 to 2022. Kacy also held the position of Counsel at Novo Nordisk between 2016 and 2019 and worked as an Associate at Kaye Scholer LLP (now Arnold & Porter) from 2010 to 2016. Additionally, they were a Law Clerk at Kaye Scholer LLP (now Arnold & Porter) in 2008 and a Student Associate at the Rutgers Constitutional Litigation Clinic from 2007 to 2008. Earlier in their career, they interned at the Urban Justice Center in 2007.
Education and Expertise
Kacy Wiggum has a J.D. from Rutgers Law School, where they studied law from 2006 to 2009. They also hold a B.A. in Communications from Lewis & Clark College, completed between 1999 and 2003. This combination of legal and communications education enhances their proficiency in regulatory law, particularly in market access, pricing, and value demonstration within the pharmaceutical industry.
Legal Experience in Regulatory Law
Kacy Wiggum possesses extensive experience in regulatory law, with a focus on market access, pricing, and value demonstration. They have handled significant legal matters at multiple pharmaceutical companies, including Bristol Myers Squibb, Bausch Health Companies Inc., and Novo Nordisk. Their roles have often involved navigating complex regulatory environments and ensuring compliance with market access protocols.